Optimasi Tablet Levofloksasin yang Mengandung Bahan Pengikat PVP K-30 dan Disintegran Vivasol
The aim of this research was to get optimal formula of levofloxacin tablet prepared with variation of PVP K-30 as binder and vivasol as disintegrant. The making of levofloxacin tablets was done by wet granulation. Tablet was prepared with various levels of PVP K-30 and disintegrant vivasol, compr...
Saved in:
Main Authors: | , , |
---|---|
格式: | Article PeerReviewed |
語言: | English English |
出版: |
2017
|
主題: | |
在線閱讀: | http://repository.unair.ac.id/75687/3/C-22%20Artikel.pdf http://repository.unair.ac.id/75687/2/C-22%20Validasi%20dan%20Peer%20Reviewer.pdf http://repository.unair.ac.id/75687/ |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
總結: | The aim of this research was to get optimal formula of levofloxacin tablet prepared
with variation of PVP K-30 as binder and vivasol as disintegrant. The making of levofloxacin tablets
was done by wet granulation. Tablet was prepared with various levels of PVP K-30 and disintegrant
vivasol, compressed using a hydraulic press with 12 mm punch diameter, for 3 seconds. Physical
quality (hardness, friability, and disintegration time) and dissolution rate of tablet was evaluated.
The optimization of the formula was done by factorial design of 22 factorial experiments with 2
factors (PVP K-30 and vivasol) and 2 levels (2% and 4%). Optimization results showed that elevated
levels of PVP K-30 increased tablet hardness, reduced friability of tablet, decreased disintegrating
time, and increased dissolution rate of levofloxacin tablets. Meanwhile, elevated levels of vivasol
increased the hardness of tablets, decreased the disintegrating time of tablets, decreased the
dissolution rate of levofloxacin tablets, but did not affect the friability of tablets. In conclusion, the
optimal tablet that meet the specifications of physical quality (hardness, friability, and disintegrating
time) and dissolution rate was made by 2.4 to 3.7% of PVP K-30 and 2.0 to 3.2% vivasol as shown
in the feasible area of design space |
---|